Eli Lilly Financial Diagnostics

LLY -- USA Stock  

USD 119.64  0.13  0.11%

The modest gains experienced by current holders of Eli Lilly may encourage investors to take a closer look at the firm as it closed today at a share price of 119.58 on very low momentum in trading volume. The company directors and management have been quite successful with maneuvering the stock at opportune times to take advantage of all market conditions in November. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.14. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. This diagnostics interface makes it easy to digest most current publicly released information about Eli Lilly as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Eli Lilly price relationship with some important fundamental indicators such as market cap and management efficiency. Please see also Stocks Correlation.

Eli Lilly Note

About 81.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.93. Eli Lilly And recorded earning per share (EPS) of 7.93. The entity last dividend was issued on 2019-11-14. The firm had 2:1 split on 1997-10-16. Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Eli Lilly operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. It employs 33910 people. To find out more about LILLY ELI CO contact John Lechleiter at 317-276-2000 or learn more at http://www.lilly.com.

Eli Lilly And Alerts

Eli Lilly And has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
Over 81.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Sale by Lilly Endowment Inc of 210000 shares of Eli Lilly

Eli Lilly And Upcoming and Recent Events

Upcoming Quarterly Earning ReportJanuary 30, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndJanuary 30, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Eli Lilly Earning Estimates

EPSEstimate Date
Quarterly Estimate1.51January 30, 2020
Eli Lilly And Company normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Eli Lilly SEC Filings

Financial Statements and Exhibits. Other Events
Financial Statements and Exhibits. Other Events
Financial Statements and Exhibits. Other Events. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Submission of Matters to a Vote of Security Holders
Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition

Eli Lilly Thematic Classifications

Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French
Compulsion IdeaCompulsion
Addiction driven consumer products and services
Drugs IdeaDrugs
Drug manufacturing and delivery

Institutional Investors

Security TypeSharesValue
Lilly Endowment IncCommon Shares116.6 M13 B
Vanguard Group IncCommon Shares71 M7.9 B
Blackrock IncCommon Shares61.1 M6.8 B
Primecap Management CoCommon Shares42.8 M4.8 B
Wellington Management Group LlpCommon Shares39.7 M4.4 B
State Street CorpCommon Shares37.1 M4.2 B
Capital International InvestorsCommon Shares25.1 M2.8 B

Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 104.71 B.

Stock Holders for Eli Lilly

Information
Ratio
Value
At Risk
NASDAQ N America Large Mid Cap 0.0303 (1.31) 
Nasdaq Dorsey Wright Peoples Po 0.07 (0.99) 
Nasdaq CRD Global Sustainabilit 0.36  0.00 
Nasdaq Singularity Net Total Re(0.20) (1.15) 
Nasdaq Singularity Index 0.16 (0.93) 
Nasdaq Victory US 500 Large Vol 0.07 (0.97) 
Nasdaq Victory US 500 Large Vol 0.05 (0.97) 
Nasdaq US Large Cap Growth NTR 0.0231 (1.63) 
NASDAQ US Large Mid Cap Index(0.0033) (1.35) 
NYSE 0.0064 (1.36) 
DWS CROCI Equity Dividend Fund 0.14 (0.92) 
Amana Mutual Funds Trust Inco 0.07 (1.46) 
Nasdaq Victory US 500 Large Vol(0.0031) (0.97) 
Nasdaq US Sustainable Momentum(0.0416) (1.52) 
Nasdaq CRD Global Sustainabilit 0.07 (0.72) 
NYSE ARCA PHARMACEUTICAL INDEX 0.0435 (1.38) 
SPDR SP Pharmaceuticals ETF 0.11 (1.69) 
SPDR Select Sector Fund Healt 0.13 (0.35) 
Vanguard Primecap Fund 0.033 (1.82) 
Vanguard PRIMECAP Core Fund Inv 0.0382 (1.51) 

Technical Drivers

As of the 8th of December Eli Lilly shows Coefficient Of Variation of 1639.87, Downside Deviation of 1.25 and Mean Deviation of 0.9285. In respect to Fundamental Indicators, Macroaxis technical analysis interface provides you with the way to check existing technical drivers of Eli Lilly as well as the relationship between them. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Eli Lilly And Company which can be compared to its rivals. Please confirm Eli Lilly And Downside Deviation, Treynor Ratio as well as the relationship between Treynor Ratio and Expected Short fall to decide if Eli Lilly And is priced favorably providing market reflects its regular price of 119.64 per share. Given that Eli Lilly has Jensen Alpha of 0.0279, we urge you verify Eli Lilly And Company prevailing market performance to make sure the company can sustain itself at future point.

Eli Lilly And Price Movement Analysis

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Eli Lilly And price series. View also all equity analysis or get more info about hilbert transform instantaneous trendline overlap studies indicator.

Eli Lilly And Insider Trading Activities

Eli Lilly Outstanding Bonds

MaturityCouponRating
532457AM0 7.125%06/01/20257.125
AA-
532457AN8 6.57%01/01/20166.57
AA-
532457AP3 6.77%01/01/20366.77
AA-
532457AX6 4.5%03/15/20184.5
AA-
532457AZ1 5.5%03/15/20275.5
AA-
532457BA5 5.55%03/15/20375.55
AA-
532457BB3 5.2%03/15/20175.2
AA-
532457BC1 5.95%11/15/20375.95
AA-
532457BF4 1.95%03/15/20191.95
AA-
532457BG2 4.65%06/15/20444.65
AA-
532457BH0 2.75%06/01/20252.75
AA-
532457BJ6 3.7%03/01/20453.7
AA-
532457BK3 1.25%03/01/20181.25
AA-

Eli Lilly Technical and Predictive Indicators

Eli Lilly Forecast Models

Recommendations

Eli Lilly And Analyst Recommendations

Target PriceAdvice# of Analysts
134.71Buy7Odds
Eli Lilly And Company current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Eli Lilly Analyst Advice  

Vital Value Indicators

Eli Lilly Basic Pricing Drivers

Quick Ratio0.66
Fifty Two Week Low101.36
Trailing Annual Dividend Rate2.50
Revenue Growth3.20%
Payout Ratio55.50%
Shares Short Prior Month11.83M
Average Daily Volume Last 10 Day2.61M
Average Daily Volume In Three Month3.19M
Earnings Growth21.80%
Shares Percent Shares Out1.06%
Gross Margins74.64%
Earnings Quarterly Growth9.10%
Short Percent Of Float1.12%
Forward Price Earnings18.12
Float Shares842.93M
Fifty Two Week High132.13
Enterprise Value To Ebitda17.29
Fifty Day Average113.06
Two Hundred Day Average112.30
Trailing Annual Dividend Yield2.10%
Enterprise Value To Revenue5.11
Please see also Stocks Correlation. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Search macroaxis.com